Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Feb;85(1):21-22.
doi: 10.18999/nagjms.85.1.21.

The fruits of CD40 research in basic and clinical medicine will soon be harvested

Affiliations
Comment

The fruits of CD40 research in basic and clinical medicine will soon be harvested

Tsutomu Kawabe. Nagoya J Med Sci. 2023 Feb.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Kawabe T, Naka T, Yoshida K, et al. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity. 1994;1(3):167–178. doi:10.1016/1074-7613(94)90095-7. - DOI - PubMed
    1. Kawabe T, Matsushima M, Hashimoto N, Imaizumi K, Hasegawa Y. CD40/CD40 ligand interactions in immune responses and pulmonary immunity. Nagoya J Med Sci. 2011;73(3–4):69–78. - PMC - PubMed
    1. Koritzinsky EH, Tsuda H, Fairchild RL. Endogenous memory T cells with donor-reactivity: Early post-transplant mediators of acute graft injury in unsensitized recipients. Transpl Int. 2021;34(8):1360–1373. doi:10.1111/tri.13900. - DOI - PMC - PubMed
    1. Louis K, Macedo C, Lefaucheur C, Metes D. Adaptive immune cell responses as therapeutic targets in antibody-mediated organ rejection. Trends Mol Med. 2022;28(3):237–250. doi:10.1016/j.molmed.2022.01.002. - DOI - PMC - PubMed
    1. Smith KE, Deronic A, Hägerbrand K, Norlén P, Ellmark P. Rationale and clinical development of CD40 agonistic antibodies for cancer immunotherapy. Expert Opin Biol Ther. 2021;21(12):1635–1646. doi:10.1080/14712598.2021.1934446. - DOI - PubMed

LinkOut - more resources